TPI Composites, Inc. is a holding company, which engages in the manufacturing of composite wind blades for the wind energy market. It operates through the following geographical segments: United States (US), Mexico, Europe, the Middle East and Africa (EMEA), and India. The US segment manufactures precision molding and assembly systems used for automotive business at Warren, Rhode Island facility. The Mexico segment includes the manufacturing of wind blades at three facilities in Juarez, Mexico, and two facilities in Matamoros, Mexico. The EMEA segment refers to the manufacturing of wind blades at two facilities in Izmir, Turkiye, and wind blade inspection and repair services in Turkiye. The India segment manufactures wind blades at manufacturing facility in Chennai, India. The company was founded by Everett Pearson and Neil Tillotson in 1968 and is headquartered in Scottsdale, AZ.

Air Industries Group is an integrated tier 1 manufacturer of precision assemblies and components for mission-critical aerospace and defense applications and is a prime contractor to the U.S. Department of Defense. The company is regarded for its expertise in manufacturing parts and assemblies that are vital for flight safety and performance, including landing gear, arresting gear, engine mounts, flight controls, and jet engine components. Its products are currently deployed on profile military aircraft such as the Sikorsky Black Hawk, Lockheed Martin F-35 Lightning II (Joint Strike Fighter), F-16 Fighting Falcon, Northrop Grumman E-2C/D, Boeing F-15 Eagle, and F-18 Hornet, as well as several commercial aircraft manufactured by Airbus and Boeing. The company was founded in 1979 and is headquartered in Bay Shore, NY.

MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its clinical-stage candidates are ETX-810 and ETX-155. ETX-810 is a novel palmitoylethanolamide (PEA) prodrug initially being developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and pain associated with lumbosacral radiculopathy. ETX-155 is a neurosteroid GABAA receptor positive allosteric modulator (PAM) initially being developed for major depressive disorder (MDD), perimenopausal depression (PMD) and focal onset seizures. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wilmington, DE.

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Exela Technologies, Inc. engages in the provision of transaction processing solutions and enterprise information management. It operates through the following segments: Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal and Loss Prevention Services (LLPS). The ITPS segment is involved in the solutions and services designed to aid businesses in information capture, processing, decisioning, and distribution to customers primarily in the financial services, commercial, public sector, and legal industries. The HS segment operates and maintains a consulting and outsourcing business specializing in both the healthcare provider and payer markets. The LLPS segment offers a broad and active array of support services in connection with class action, bankruptcy labor, claims adjudication and employment, and other legal matters. The company was founded in 2004 and is headquartered in Irving, TX.

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.